Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Finley

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Cancer Treatment and Research Communications|March 12, 2021
Chemotherapy use in early stage anal canal squamous cell carcinoma and its impact on long-term overall survival<sup>,,</sup>Deanna L Huffman, Thejus T Jayakrishnan, Brittany L Vannatter, et al.
Cancer Research|November 1, 1992
Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumorsM F Melhem, A I Meisler, G G Finley, et al.
Clinical Lung Cancer|April 18, 2019
Chemotherapy Versus Supportive Care for Unresected Malignant Pleural MesotheliomaVivek Verma, Rodney E Wegner, Eric D Brooks, et al.
Biomarker Research|November 15, 2022
Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinomaHirsch Matani, Divya Sahu, Michael Paskewicz, et al.
JAMA Oncology|February 16, 2023
Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non-Small Cell Lung Cancer: Pooled Analyses of the Phase 3 IMpower130, IMpower132, and IMpower150 Randomized Clinical TrialsMark A Socinski, Robert M Jotte, Federico Cappuzzo, et al.
Annals of Surgery|July 30, 2016
PI3K/mTOR Dual Inhibitor, LY3023414, Demonstrates Potent Antitumor Efficacy Against Esophageal Adenocarcinoma in a Rat ModelAli H Zaidi, Juliann E Kosovec, Daisuke Matsui, et al.
Oncotarget|March 4, 2021
Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma modelAli H Zaidi, Ronan J Kelly, Anastasia Gorbunova, et al.
Oncotarget|October 30, 2016
Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinomaDaisuke Matsui, Ali H Zaidi, Samantha A Martin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 9, 1998
WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumorsD Pennica, T A Swanson, J W Welsh, et al.
Space Science Reviews|July 7, 2025
The MAGnetometers for Innovation and Capability (MAGIC) Technology Demonstration PayloadDavid M Miles, Amanda Lasko, Scott Bounds, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Cancer Treatment and Research Communications|March 12, 2021
Chemotherapy use in early stage anal canal squamous cell carcinoma and its impact on long-term overall survival<sup>,,</sup>Deanna L Huffman, Thejus T Jayakrishnan, Brittany L Vannatter, et al.
Cancer Research|November 1, 1992
Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumorsM F Melhem, A I Meisler, G G Finley, et al.
Clinical Lung Cancer|April 18, 2019
Chemotherapy Versus Supportive Care for Unresected Malignant Pleural MesotheliomaVivek Verma, Rodney E Wegner, Eric D Brooks, et al.
Biomarker Research|November 15, 2022
Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinomaHirsch Matani, Divya Sahu, Michael Paskewicz, et al.
JAMA Oncology|February 16, 2023
Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non-Small Cell Lung Cancer: Pooled Analyses of the Phase 3 IMpower130, IMpower132, and IMpower150 Randomized Clinical TrialsMark A Socinski, Robert M Jotte, Federico Cappuzzo, et al.
Annals of Surgery|July 30, 2016
PI3K/mTOR Dual Inhibitor, LY3023414, Demonstrates Potent Antitumor Efficacy Against Esophageal Adenocarcinoma in a Rat ModelAli H Zaidi, Juliann E Kosovec, Daisuke Matsui, et al.
Oncotarget|March 4, 2021
Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma modelAli H Zaidi, Ronan J Kelly, Anastasia Gorbunova, et al.
Oncotarget|October 30, 2016
Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinomaDaisuke Matsui, Ali H Zaidi, Samantha A Martin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 9, 1998
WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumorsD Pennica, T A Swanson, J W Welsh, et al.
Space Science Reviews|July 7, 2025
The MAGnetometers for Innovation and Capability (MAGIC) Technology Demonstration PayloadDavid M Miles, Amanda Lasko, Scott Bounds, et al.
Pageof 8